Studies on the efficacy of Rubrivivaxin and Rhodethrin as novel inhibitors for aromatase in ER Pristive Breast cancer Cells | India Science, Technology & Innovation - ISTI Portal

×

Acces sibility Controls

Studies on the efficacy of Rubrivivaxin and Rhodethrin as novel inhibitors for aromatase in ER Pristive Breast cancer Cells

Implementing Organization

Central University of Kerala

Principal Investigator

Dr. Ranjith n Kumavath

Assistant Professor

|

Central University of Kerala

Department of Genomic Sciences

Related Research

Quick Information

Area of Research

Life Sciences & Biotechnology

Focus Area

Breast cancer Cells

Start Year

2016

Sanction Amount

₹ 44.29 L

Status

Ongoing

Contact

RNKumavath@cukerala.ac.in

Output

No. of Research Paper

00

Technologies (If Any)

00

No. of PhD Produced

00

No. of Patents

Filed : 00

Grant : 00